MYRIAD GENETICS (MYGN) 8-K SUMMARY
Filing Date: November 3, 2025
Material Event: Item 2.02 reporting of financial results.
Key Information: Myriad Genetics announced financial results for the three months ended September 30, 2025.
Investor Action: Detailed financial performance metrics are provided in Exhibit 99.1 (Earnings Release), which is incorporated by reference.
Note: The 8-K body contains standard cautionary language regarding forward-looking statements.
Myriad Genetics Q3 2025 Investor Snapshot
Q3 revenue was $205.7M (-4% YoY),
...